“surfing the pipeline” - bizint solutions - bizint ...€¦ · citeline pharmaprojects 29% adis...

28
BizInt Smart Charts 2014 1 Pharma-Bio-Med, Rome November 2014 Diane Webb, President “Surfing the Pipeline” Comparing Drug Pipeline Database Coverage and Content

Upload: hoangthuan

Post on 29-Jul-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 1

Pharma-Bio-Med, Rome November 2014 Diane Webb, President

“Surfing the Pipeline” Comparing Drug Pipeline Database Coverage and Content

Page 2: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 2

Ten Techniques to Visualize Clinical Trials

Page 3: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 3

BizInt Smart Charts Product Family

Provides corporate information analysts with software tools to create reports and visualizations integrating information from their key sources.

Page 4: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 4

“Cookbook” of techniques

• The Cookbook contains a collection of recipes to help you create accurate and appealing products from your raw ingredients.

• Step-by-step recipes illustrate how each tool can be used.

• Substitute ingredients as needed to answer your business questions.

Page 5: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 5

Drug Pipeline Databases Provide data on drugs in development worldwide

• Citeline Pharmaprojects • IMS R&D Focus • Adis R&D Insight • Thomson Reuters Cortellis • Thomson Reuters Integrity Slides at www.bizint.com/slides

Page 6: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 6

Case study: Hepatitis C Pipeline

Query: indication = Hepatitis C, all phases (exact query differs by database)

Records retrieved: Cortellis: 777 Integrity: 359 Pharmaprojects: 689 R&D Focus: 420 R&D Insight: 474 Import search results and use File|Combine

to create a single multi-database chart

Page 7: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 7

Identify related records across databases

*

Tools | Generate Common Drug Name identifies records for the same drug by matching drug names and synonyms.

Page 8: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 8

25%

15%

17%

29%

13%

45%

27%

31%

51%

23%

0% 10% 20% 30% 40% 50% 60%

Citeline Pharmaprojects

IMS R&D Focus

Adis R&D Insight

Thomson Reuters Cortellis

Thomson Reuters Integrity

% of Drugs vs. Records Retrieved from each Database (Indication = Hepatitis C)

% of Drugs (Total of all DBs)

% of All Records Retrieved

Database Coverage Analysis

* Drugs (Total of all DBs) identified using the “Generate Common Drug Name” tool.

*

Page 9: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 9

Thomson Reuters Cortellis

35%

Citeline Pharmaprojects

29%

Adis R&D Insight 15%

IMS R&D Focus 17%

Thomson Reuters Integrity

Compounds 4%

Distribution of drugs found in a single database

Page 10: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 10

Database Coverage by Phase (records)

64

182 127

194

93

92

113

114

127

171 64

25

49

102

52 84

100 149

144

43

385 35

210

0

100

200

300

400

500

600

700

800

All All All All All

Pharmaprojects R&D Focus R&D Insight Cortellis Integrity

# of Records by Highest Phase (for all indications )

No Dev Rep

Discontinued

Launched

Clinical

Discovery

Page 11: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 11

Highest phase for indication of interest

We know the “Highest Phase” for all indications, but the phase for our indication of interest (Hep-C) is buried in the Drug Development Phase table.

Page 12: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 12

Extracting the highest phase for Hep-C

Export to VantagePoint-Smart Charts Edition

Page 13: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 13

Extracting the highest phase for Hep-C

Need to filter and clean-up indications.

Page 14: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 14

Extracting highest phase for Hepatitis-C

Cleanup Hep-C indication

Page 15: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 15

Extracting highest phase for Hepatitis-C

Filter the Drug Development Phase table to include only

the Hepatitis C entries.

Page 16: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 16

Extracting highest phase for Hepatitis-C

Export to BizInt Smart Charts as a new column.

Page 17: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 17

Extracting highest phase for Hepatitis-C

Page 18: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 18

64 65

182 159 127 117 194 195

93 100

92 82

113 110

114 110

127 124

171 184 64 52

25 20 49

38

102 84

52 31 84

85

100 97

149 163

144 113

43 43

385 405 35 46

210 261

0

100

200

300

400

500

600

700

800

All Hep C All Hep C All Hep C All Hep C All Hep C

Pharmaprojects R&D Focus R&D Insight Cortellis Integrity

# of Records by Phase (for all indications and Hepatitis C)

No Dev Rep

Discontinued

Launched

Clinical

Discovery

Database Coverage by Phase (# of records)

Page 19: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 19

Database Coverage by Phase (%)

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

All Hep C All Hep C All Hep C All Hep C All Hep C

Pharmaprojects R&D Focus R&D Insight Cortellis Integrity

Distribution of Records by Phase (for all indications and Hepatitis C)

No Dev Rep

Discontinued

Launched

Clinical

Discovery

Page 20: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 20

Summarize differences between databases

Page 21: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 21

Summarize differences between databases

Create a summary table with database, phase and

update date

Page 22: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 22

Summarize differences between databases

Apply the “Summarize All Values” rule to the new

summary table

Page 23: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 23

Summarize differences between databases

Page 24: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 24

Analyze differences in phases (hep-c vs all)

Use “Compare Columns” to find drugs with different phase for Hep-C than for all indications

Page 25: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 25

Analyze differences in phases (hep-c vs all)

Create a Bubble Graph in VP-SCE to spot trends

Page 26: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 26

Analyze differences in phases (hep-c vs all)

Create a Bubble Graph in VP-SCE to spot trends

Marketed Drugs in Phase 2 for Hepatitis C

Page 27: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 27

“Surfing the Pipeline” - conclusions

Pipeline databases continue to vary in coverage and content.

The more pipeline databases you use, the better you can exploit the strengths of each.

BizInt Smart Charts tools can help you aggregate, summarize and visualize multi-database pipeline information…

…to create more accurate and effective pipeline intelligence!

Page 28: “Surfing the Pipeline” - BizInt Solutions - BizInt ...€¦ · Citeline Pharmaprojects 29% Adis R&D Insight 15% . IMS R&D Focus 17% Thomson Reuters Integrity ... “Surfing the

BizInt Smart Charts 2014 28

Visit our stand for more info and to see the

Cookbook!

www.bizint.com